Radiomics in rectal cancer: current status of use and advances in research
Rectal cancer is a leading cause of morbidity and mortality among patients with malignant tumors in China. In light of the advances made in therapeutic approaches such as neoadjuvant therapy and total mesorectal excision, precise preoperative assessment has become crucial for developing a personaliz...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1470824/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841525892546822144 |
|---|---|
| author | Wei-Qin Huang Ruo-Xuan Lin Xiao-Hui Ke Xiao-Hong Deng Shi-Xiong Ni Lina Tang |
| author_facet | Wei-Qin Huang Ruo-Xuan Lin Xiao-Hui Ke Xiao-Hong Deng Shi-Xiong Ni Lina Tang |
| author_sort | Wei-Qin Huang |
| collection | DOAJ |
| description | Rectal cancer is a leading cause of morbidity and mortality among patients with malignant tumors in China. In light of the advances made in therapeutic approaches such as neoadjuvant therapy and total mesorectal excision, precise preoperative assessment has become crucial for developing a personalized treatment plan. As an emerging technology, radiomics has gained widespread application in the diagnosis, assessment of treatment response, and analysis of prognosis for rectal cancer by extracting high-throughput quantitative features from medical images. Radiomics thus demonstrates considerable potential for optimizing clinical decision-making. In this paper, we reviewed recent research focusing on advances in the use of radiomics for managing rectal cancer. The review covers TNM staging of tumors, assessment of neoadjuvant therapy outcomes, and survival prediction. We also discuss the challenges and prospects for future developments in translational medicine, particularly the need for data standardization, consistent feature extraction methodologies, and rigorous model validation. |
| format | Article |
| id | doaj-art-e6707f52dfc142ef9431fdccef5c56c1 |
| institution | Kabale University |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-e6707f52dfc142ef9431fdccef5c56c12025-01-17T06:50:31ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.14708241470824Radiomics in rectal cancer: current status of use and advances in researchWei-Qin HuangRuo-Xuan LinXiao-Hui KeXiao-Hong DengShi-Xiong NiLina TangRectal cancer is a leading cause of morbidity and mortality among patients with malignant tumors in China. In light of the advances made in therapeutic approaches such as neoadjuvant therapy and total mesorectal excision, precise preoperative assessment has become crucial for developing a personalized treatment plan. As an emerging technology, radiomics has gained widespread application in the diagnosis, assessment of treatment response, and analysis of prognosis for rectal cancer by extracting high-throughput quantitative features from medical images. Radiomics thus demonstrates considerable potential for optimizing clinical decision-making. In this paper, we reviewed recent research focusing on advances in the use of radiomics for managing rectal cancer. The review covers TNM staging of tumors, assessment of neoadjuvant therapy outcomes, and survival prediction. We also discuss the challenges and prospects for future developments in translational medicine, particularly the need for data standardization, consistent feature extraction methodologies, and rigorous model validation.https://www.frontiersin.org/articles/10.3389/fonc.2024.1470824/fullprognosisradiomicsrectal cancerresponse to neoadjuvantstaging |
| spellingShingle | Wei-Qin Huang Ruo-Xuan Lin Xiao-Hui Ke Xiao-Hong Deng Shi-Xiong Ni Lina Tang Radiomics in rectal cancer: current status of use and advances in research Frontiers in Oncology prognosis radiomics rectal cancer response to neoadjuvant staging |
| title | Radiomics in rectal cancer: current status of use and advances in research |
| title_full | Radiomics in rectal cancer: current status of use and advances in research |
| title_fullStr | Radiomics in rectal cancer: current status of use and advances in research |
| title_full_unstemmed | Radiomics in rectal cancer: current status of use and advances in research |
| title_short | Radiomics in rectal cancer: current status of use and advances in research |
| title_sort | radiomics in rectal cancer current status of use and advances in research |
| topic | prognosis radiomics rectal cancer response to neoadjuvant staging |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2024.1470824/full |
| work_keys_str_mv | AT weiqinhuang radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch AT ruoxuanlin radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch AT xiaohuike radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch AT xiaohongdeng radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch AT shixiongni radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch AT linatang radiomicsinrectalcancercurrentstatusofuseandadvancesinresearch |